Methylene Blue for Depression and Mood: What the Research Shows
Most people discover methylene blue through the cognitive enhancement or longevity rabbit hole. The mood research tends to come as a surprise.
MB has been studied as an antidepressant since at least the 1980s. A 1987 clinical trial published in Biological Psychiatry found that low-dose methylene blue significantly improved symptoms in patients with manic-depressive psychosis. A 1984 study found similar results in severe depressive states. These weren't fringe papers — they were published, peer-reviewed clinical trials at a time when the modern SSRI era was barely beginning.
That history is worth knowing. It changes how you think about what this compound actually does.
If you're new to MB, start with our full overview first.
Why Methylene Blue Affects Mood
There are several overlapping mechanisms.
MAO inhibition
Methylene blue is a reversible inhibitor of monoamine oxidase (MAO) — the enzyme that breaks down serotonin, dopamine, and norepinephrine. By inhibiting MAO, MB increases the availability of these neurotransmitters in the synaptic cleft.
This is the same basic mechanism as MAOI antidepressants — one of the oldest and most effective classes of antidepressant medication. MB is a weak, reversible MAO inhibitor at low doses, which is why its effect is more subtle than pharmaceutical MAOIs and why its interaction risk with serotonergic drugs still needs to be taken seriously.
If you're currently on an SSRI or SNRI, please read our safety and side effects post before considering MB.
Mitochondrial energy in the brain
Depression has an increasingly recognised metabolic component. Brain imaging studies consistently show reduced metabolic activity in prefrontal regions in people with depression — in plain terms, the depressed brain is running low on energy.
MB's primary mechanism is mitochondrial enhancement. By improving electron transport chain efficiency and increasing ATP production in neurons, it directly addresses this energy deficit. This is a different pathway to conventional antidepressants, which almost exclusively target neurotransmitter reuptake rather than cellular energy.
For the full breakdown of MB's mitochondrial brain effects, see Your Brain's Best Friend.
Neuroinflammation reduction
Neuroinflammation is increasingly understood as a driver of depressive symptoms — particularly treatment-resistant depression. MB has documented anti-inflammatory effects in the brain, reducing inflammatory cytokines and protecting neurons from oxidative damage.
This anti-inflammatory mechanism overlaps with the protection MB offers against modern stressors. See our post on MB and modern life for more on that angle.
What the Clinical Research Shows
The most relevant studies:
A 1984 study in the Journal of Psychiatry found methylene blue produced significant improvement in patients with severe depressive states compared to placebo.
A 1987 clinical trial found MB effective in reducing symptoms of manic-depressive psychosis — specifically the depressive phase — at low oral doses.
A 2016 study explored MB's role in cognitive function and neuropsychiatric conditions, noting its potential across depression, anxiety, and cognitive decline through multiple converging mechanisms.
The full citations are available in our research master list.
The Mood-Energy Connection
One thing that stands out about MB's reported mood effects — both in research and anecdotally — is how they're described. People don't typically report a sedating or numbing effect. They report feeling more energised, clearer, and more motivated.
This makes sense mechanistically. MB isn't blunting anything — it's improving energy metabolism in the brain. The mood lift comes from the brain functioning better, not from pharmacologically suppressing anything.
This is a fundamentally different model to most antidepressants. And for people who find SSRIs flatten affect or reduce motivation, it's a meaningful distinction.
Stacking for Mood
Several practices complement MB for mood support:
Sunlight and red light therapy target similar mitochondrial pathways in the brain. The combination of MB with morning sunlight or red light exposure is one of the most commonly cited stacks in the biohacking community for mood and energy. See our red light and MB post for the full picture.
Fasting, particularly intermittent fasting, also activates AMPK and autophagy pathways that complement MB's effects. See our fasting post for how to combine them.
An Important Note
This post is not suggesting methylene blue as a treatment for clinical depression. If you're experiencing depression, please speak to a qualified healthcare professional.
What this post is saying is that MB has documented mechanisms that affect mood-relevant biology — MAO inhibition, mitochondrial energy enhancement, neuroinflammation reduction — and clinical research going back 40 years that the mainstream conversation largely ignores.
For people looking to support mood, motivation, and mental energy through a bioenergetic approach, it's a compound worth understanding.
Start at a low dose, track how you feel, and work up gradually. Our dosing guide has everything you need to get started safely.
Disclaimer: This post is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement, particularly if you are managing a mental health condition or taking any medication.